SciELO - Scientific Electronic Library Online

 
vol.14 número1Serological detection of brucellosis among febrile, malaria-negative children and domesticated dogs in an urban African settingPostmortem diagnosis of COVID-19: Antemortem challenges of three cases at the 37 Military Hospital, Accra, Ghana índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

    Links relacionados

    • En proceso de indezaciónCitado por Google
    • En proceso de indezaciónSimilares en Google

    Compartir


    African Journal of Laboratory Medicine

    versión On-line ISSN 2225-2010versión impresa ISSN 2225-2002

    Resumen

    OBADARE, Temitope O. et al. Bacterial agents and antibiotic resistance in febrile neutropaenia in Africa: A systematic review and meta-analysis. Afr. J. Lab. Med. [online]. 2025, vol.14, n.1, pp.1-9. ISSN 2225-2010.  https://doi.org/10.4102/ajlm.v14i1.2816.

    BACKGROUND: Febrile neutropaenia (FN) is an oncology emergency, but there is a paucity of data on it in Africa AIM: This study aimed to review and aggregate data on FN in the context of antibiotic resistance METHODS: Published original articles between 1991 and 2024 were systematically searched in Google Scholar, PubMed, and African Journals Online databases (grey literature excluded). 'Febrile neutropenia' was combined by Boolean terms 'OR' and 'AND' with individual countries for the searched terms. Data aggregation on bacteria isolates and antibiotics was done using Microsoft Excel RESULTS: Of 16 637 articles retrieved, 15 (from nine countries) with 1216 non-duplicate isolates were included in the analyses after exclusion of irrelevant and duplicate articles. There were 57.0% (698/1225) Gram-positive and 43.3% (527/1225) Gram-negative bacteria. Aggregated resistance to antibiotics for Gram-positive bacteria was 71.8% (163/227), for ampicillin, 74.3% (226/304), for cefoxitin, 64.1% (25/39), and 54.0% (47/87) for oxacillin, while that of Gram-negative bacteria was 35.5% (184/519) for ciprofloxacin, 60.6% (168/277) for ceftriaxone, 65.9% (89/135) for cefuroxime, and 38.2% (153/401) for imipenem. Staphylococcus aureus had 68.8% (22/32) resistance to oxacillin/methicillin and 10% (1/10) resistance to vancomycin. Klebsiella spp. was 50% (9/18) resistant to quinolones, 75.9% (22/29) resistant to third-generation cephalosporins, and 25.0% (4/16) resistant to carbapenems, while Acinetobacter spp. was 85.7% (6/7) resistant to gentamycin CONCLUSION: This review highlighted the paucity of data and the emergence of multidrug resistance in FN in Africa. There is a need for antibiotic-resistance surveillance and antibiotic stewardship to optimise therapy in FN in Africa WHAT THIS STUDY ADDS: To the best of our knowledge, this is the first systematic review of FN in Africa in the context of available laboratory resources across the African regions

    Palabras clave : febrile-neutropaenia; bloodstream-infection; bacterial agents; multi-drug resistance; Africa.

            · texto en Inglés     · Inglés ( pdf )